Viewing Study NCT04826003


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2025-12-29 @ 6:47 AM
Study NCT ID: NCT04826003
Status: COMPLETED
Last Update Posted: 2025-07-14
First Post: 2021-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module